TRADOL-50
TRADOL-50
Finished Goods / Analgesics, Antipyretics, Anti-Inflammatory drugs
-Tramadol is a centrally acting synthetic analgesic compound.
Its analgesic effects are mediated via both the stimulation of
μ-opioid receptors and indirect modulation of central
monoaminergic inhibitory pain pathways.
- Tramadol is rapidly and almost completely absorbed after
oral administration and extensively metabolized.
- Analgesic effect begins approximately within one hour after
administration and reaches a peak in approximately two to
three hours.
- Tramadol is widely distributed, crosses the placenta , and
appears in small amount in breast milk.
- Approximately 30% of the dose is excreted in the urine as
unchanged drug, whereas 60% of the dose is excreted as
metabolites.
- The elemination half-life of Tramadol is about 6 hours after
oral administration.
Its analgesic effects are mediated via both the stimulation of
μ-opioid receptors and indirect modulation of central
monoaminergic inhibitory pain pathways.
- Tramadol is rapidly and almost completely absorbed after
oral administration and extensively metabolized.
- Analgesic effect begins approximately within one hour after
administration and reaches a peak in approximately two to
three hours.
- Tramadol is widely distributed, crosses the placenta , and
appears in small amount in breast milk.
- Approximately 30% of the dose is excreted in the urine as
unchanged drug, whereas 60% of the dose is excreted as
metabolites.
- The elemination half-life of Tramadol is about 6 hours after
oral administration.
Indication
TRADOL® is indicated in management of moderate to
severe pain.
Dosage & Administration
The dosage should be adjusted to the intensity of the pain.
Unless otherwise prescribed, TRADOL® should be
administered as follow:
-Single dose for adult and adolescents over 12 years of age:
1-2 capsules (to be taken with a little liquid) and total daily
dosage should not exceed 400mg (8 capsules).
-In elderly patients (over 75 Years) and renal insufficiency
or hepatic insufficiency:
It may be necessary to prolong the dosage intervals to reach 12
hours.
-Children:
TRADOL® capsules are not intended for use in children
weighing less than 25 kg & generally do not allow individual
dosing in children below the age of 12 years. Therefore more
suitable formulations are to be used.
- Each capsule of TRADOL® 50 contains:
Tramadol hydrochloride 50 mg.
TRADOL® is contraindicated in known hypersensitivity
towards Tramadol.
- in acute intoxication with alcohol, hypnotics, analgesics,
opioids, or other psychotropic drugs.
- also in patients who are receiving MAO inhibitors or who have
taken them within the last 14 days.
- Carbamazepine is reported to diminish the analgesic activity of
Tramadol by reducing serum concentrations.
- Tramadol inhibits reuptake of noradrenaline and serotonin and enhances serotonin release and there is the possibility that it
may interact with other drugs that enhance monoaminergic
neurotransmission including:
Lithium, tricyclic antidepressants and selective serotonin
reuptake inhibitors.
- Quinidine may increase concentrations of Tramadol and
lower concentrations of its active metabolite.
-TRADOL® should not be used in pregnant women prior to or
during labor.
-TRADOL® is not recommended for post delivery analgesia in
nursing mothers because its safety in infants and newborns has
not been studied.
Frequently: nausea and dizziness.
- Occasionally: vomiting, constipation, sweating, dry mouth,
headache, drowsiness.
- Rarely: effect on circulatory regulation (palpitations,
tachycardia, feeling of weakness), gastrointestinal irritation, skin
reactions (pruritus, rash, urticaria.)
- Very rarely: epileptic seizures, hypertension, bradycardia, and
respiratory depression.
- Blister of 10 capsules, Pack of one blister.
- Hospital packs of different sizes.
-Store in a dry place below 25oC.